Global Pleuromutilin Market Research Report 2026

Pleuromutilin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pleuromutilin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Pleuromutilin is a broad-spectrum diterpene antibiotic produced by Pleurotus mutilus. It is the precursor of semi-synthetic derivatives of pleuromutilin and can effectively inhibit most Gram-negative bacteria. positive bacteria and some Gram-negative bacteria. Pleuromutilin is a class of antibacterial substances that work by inhibiting the synthesis of protein in bacteria. Pleuromutilins were discovered in the 1950s mainly for veterinary purposes. Pleuromutilin is used for the treatment and prevention of gastrointestinal and respiratory infections caused by different bacterial pathogens in pigs, poultry and rabbits. In our report, our statistical standard is based on 100% content. Active Ingredient Contents is 100%.In 2025, global Pleuromutilin production reached approximately 2557 MT and price is about 38.5 USD/Kg.The average gross profit margin of this product is 13%.

Rising biosecurity expectations and the operational needs of large-scale farming are reinforcing “health management to protect production efficiency” as a durable spending driver. In this environment, clinically familiar pleuromutilin-class solutions remain strategically relevant in key swine respiratory and mycoplasma-related scenarios. In parallel, regulators are advancing prudent use, prescription control, and AMR-oriented oversight, pushing the industry away from extensive use toward standardized, compliant programs. This structural shift favors suppliers that can deliver consistency, registrations, and customer support through a robust compliance and quality system. The veterinary antibacterial segment faces multi-layer constraints: AMR governance tightens prescription compliance, indication boundaries, and intensity management; food safety and residue frameworks raise customer expectations for batch consistency, impurity control, and traceable documentation; and leading animal-health companies increasingly emphasize responsible use and portfolio mix evolution in their annual reporting—signaling a market where compliance execution and solution capability matter as much as price. Collectively, these forces elevate the integrated bar across registration, QA, and channel access. Demand is shifting from “treatment only” to “a component of farm management.” Producers increasingly seek test-informed, segmented medication, better course compliance, and closed-loop recording to reduce systemic outbreak risk. Meanwhile, the implementation of modern veterinary-medicine rules in markets such as the EU further strengthens requirements around prescription justification and process traceability, encouraging more standardized dosage forms and stronger service/tooling around compliant execution. Broker research commonly frames animal-health opportunity around scale-up, compliance upgrading, and substitution/upgrade dynamics—favoring suppliers with dependable delivery and governance-ready operating models. Upstream competitiveness is shaped less by “raw materials” alone and more by reproducible process control and auditable quality systems. For pleuromutilin derivatives, upstream typically spans fermentation-linked nucleus/intermediate sourcing, semi-synthetic reaction inputs (reagents/solvents), and controlled salt formation plus crystallization/purification steps. Veterinary GMP and regulatory expectations convert quality management, documentation, and on-site consistency into non-negotiable requirements, accelerating upstream consolidation toward compliant, scalable, audit-ready operations. In practice, sustainable advantage comes from high-yield scale-up, stable impurity profiles, continuous supply, and audit pass-rates—ultimately reinforcing brand trust and customer stickiness.

This report delivers a comprehensive overview of the global Pleuromutilin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pleuromutilin. The Pleuromutilin market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pleuromutilin market comprehensively. Regional market sizes by Type, by Application, by Salt Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pleuromutilin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pleuromutilin Market Report

Chapter Outline

1.1 Product Definition

1.2 Pleuromutilin by Type

1.2.1 Global Pleuromutilin Market Value by Type: 2025 vs 2032

1.2.2 Premix

1.2.3 API Powder

1.3 Pleuromutilin by Salt Form

1.3.1 Global Pleuromutilin Market Value by Salt Form: 2025 vs 2032

1.3.2 Fumarates

1.3.3 Tartrates

1.3.4 Others

1.4 Pleuromutilin by Indication Cluster

1.4.1 Global Pleuromutilin Market Value by Indication Cluster: 2025 vs 2032

1.4.2 Respiratory

1.4.3 Digestiv

1.4.4 Other

1.5 Pleuromutilin by Application

1.5.1 Global Pleuromutilin Market Value by Application: 2025 vs 2032

1.5.2 Livestock

1.5.3 Poultry

1.6 Global Pleuromutilin Market Size Estimates and Forecasts

1.6.1 Global Pleuromutilin Revenue 2021–2032

1.6.2 Global Pleuromutilin Sales 2021–2032

1.6.3 Global Pleuromutilin Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2.1 Global Pleuromutilin Sales Market Share by Manufacturers (2021–2026)

2.2 Global Pleuromutilin Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Pleuromutilin Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Pleuromutilin, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Pleuromutilin, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Pleuromutilin, Product Types and Applications

2.7 Global Key Manufacturers of Pleuromutilin, Date of Entry into the Industry

2.8 Global Pleuromutilin Market Competitive Situation and Trends

2.8.1 Global Pleuromutilin Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Pleuromutilin Players Market Share by Revenue

2.8.3 Global Pleuromutilin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Pleuromutilin Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Pleuromutilin Sales by Region: 2021–2032

3.2.1 Global Pleuromutilin Sales by Region: 2021–2026

3.2.2 Global Pleuromutilin Sales by Region: 2027–2032

3.3 Global Pleuromutilin Revenue by Region: 2021–2032

3.3.1 Global Pleuromutilin Revenue by Region: 2021–2026

3.3.2 Global Pleuromutilin Revenue by Region: 2027–2032

3.4 North America Pleuromutilin Market Facts & Figures by Country

3.4.1 North America Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Pleuromutilin Sales by Country (2021–2032)

3.4.3 North America Pleuromutilin Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 United States

3.4.6 Canada

3.5 Europe Pleuromutilin Market Facts & Figures by Country

3.5.1 Europe Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Pleuromutilin Sales by Country (2021–2032)

3.5.3 Europe Pleuromutilin Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 Poland

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.5.9 Rest of Europe

3.6 Asia Pacific Pleuromutilin Market Facts & Figures by Region

3.6.1 Asia Pacific Pleuromutilin Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Pleuromutilin Sales by Region (2021–2032)

3.6.3 Asia Pacific Pleuromutilin Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pleuromutilin Market Facts & Figures by Country

3.7.1 Latin America Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Pleuromutilin Sales by Country (2021–2032)

3.7.3 Latin America Pleuromutilin Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pleuromutilin Market Facts & Figures by Country

3.8.1 Middle East and Africa Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Pleuromutilin Sales by Country (2021–2032)

3.8.3 Middle East and Africa Pleuromutilin Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Pleuromutilin Sales by Type (2021–2032)

4.1.1 Global Pleuromutilin Sales by Type (2021–2026)

4.1.2 Global Pleuromutilin Sales by Type (2027–2032)

4.1.3 Global Pleuromutilin Sales Market Share by Type (2021–2032)

4.2 Global Pleuromutilin Revenue by Type (2021–2032)

4.2.1 Global Pleuromutilin Revenue by Type (2021–2026)

4.2.2 Global Pleuromutilin Revenue by Type (2027–2032)

4.2.3 Global Pleuromutilin Revenue Market Share by Type (2021–2032)

4.3 Global Pleuromutilin Price by Type (2021–2032)

5.1 Global Pleuromutilin Sales by Application (2021–2032)

5.1.1 Global Pleuromutilin Sales by Application (2021–2026)

5.1.2 Global Pleuromutilin Sales by Application (2027–2032)

5.1.3 Global Pleuromutilin Sales Market Share by Application (2021–2032)

5.2 Global Pleuromutilin Revenue by Application (2021–2032)

5.2.1 Global Pleuromutilin Revenue by Application (2021–2026)

5.2.2 Global Pleuromutilin Revenue by Application (2027–2032)

5.2.3 Global Pleuromutilin Revenue Market Share by Application (2021–2032)

5.3 Global Pleuromutilin Price by Application (2021–2032)

6.1 Sunny Biotech

6.1.1 Sunny Biotech Company Information

6.1.2 Sunny Biotech Description and Business Overview

6.1.3 Sunny Biotech Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Sunny Biotech Pleuromutilin Product Portfolio

6.1.5 Sunny Biotech Recent Developments/Updates

6.2 Hebei Weiyuan

6.2.1 Hebei Weiyuan Company Information

6.2.2 Hebei Weiyuan Description and Business Overview

6.2.3 Hebei Weiyuan Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Hebei Weiyuan Pleuromutilin Product Portfolio

6.2.5 Hebei Weiyuan Recent Developments/Updates

6.3 Shandong Shengli

6.3.1 Shandong Shengli Company Information

6.3.2 Shandong Shengli Description and Business Overview

6.3.3 Shandong Shengli Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Shandong Shengli Pleuromutilin Product Portfolio

6.3.5 Shandong Shengli Recent Developments/Updates

6.4 Shandong Lukang

6.4.1 Shandong Lukang Company Information

6.4.2 Shandong Lukang Description and Business Overview

6.4.3 Shandong Lukang Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Shandong Lukang Pleuromutilin Product Portfolio

6.4.5 Shandong Lukang Recent Developments/Updates

6.5 Qingdao Dierman

6.5.1 Qingdao Dierman Company Information

6.5.2 Qingdao Dierman Description and Business Overview

6.5.3 Qingdao Dierman Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Qingdao Dierman Pleuromutilin Product Portfolio

6.5.5 Qingdao Dierman Recent Developments/Updates

6.6 Qilu Pharma

6.6.1 Qilu Pharma Company Information

6.6.2 Qilu Pharma Description and Business Overview

6.6.3 Qilu Pharma Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Qilu Pharma Pleuromutilin Product Portfolio

6.6.5 Qilu Pharma Recent Developments/Updates

6.7 Huvepharma

6.7.1 Huvepharma Company Information

6.7.2 Huvepharma Description and Business Overview

6.7.3 Huvepharma Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Huvepharma Pleuromutilin Product Portfolio

6.7.5 Huvepharma Recent Developments/Updates

6.8 Novartis

6.8.1 Novartis Company Information

6.8.2 Novartis Description and Business Overview

6.8.3 Novartis Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Novartis Pleuromutilin Product Portfolio

6.8.5 Novartis Recent Developments/Updates

6.9 Vethellas

6.9.1 Vethellas Company Information

6.9.2 Vethellas Description and Business Overview

6.9.3 Vethellas Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Vethellas Pleuromutilin Product Portfolio

6.9.5 Vethellas Recent Developments/Updates

6.10 Elanco

6.10.1 Elanco Company Information

6.10.2 Elanco Description and Business Overview

6.10.3 Elanco Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Elanco Pleuromutilin Product Portfolio

6.10.5 Elanco Recent Developments/Updates

7.1 Pleuromutilin Industry Chain Analysis

7.2 Pleuromutilin Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pleuromutilin Production Mode & Process Analysis

7.4 Pleuromutilin Sales and Marketing

7.4.1 Pleuromutilin Sales Channels

7.4.2 Pleuromutilin Distributors

7.5 Pleuromutilin Customer Analysis

8.1 Pleuromutilin Industry Trends

8.2 Pleuromutilin Market Drivers

8.3 Pleuromutilin Market Challenges

8.4 Pleuromutilin Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Pleuromutilin Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Pleuromutilin Market Value by Salt Form (US$ Million), 2025 vs 2032

 Table 3. Global Pleuromutilin Market Value by Indication Cluster (US$ Million), 2025 vs 2032

 Table 4. Global Pleuromutilin Market Value by Application (US$ Million), 2025 vs 2032

 Table 5. Global Pleuromutilin Market Competitive Situation by Manufacturers in 2025

 Table 6. Global Pleuromutilin Sales (MT) of Key Manufacturers (2021–2026)

 Table 7. Global Pleuromutilin Sales Market Share by Manufacturers (2021–2026)

 Table 8. Global Pleuromutilin Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 9. Global Pleuromutilin Revenue Share by Manufacturers (2021–2026)

 Table 10. Global Market Pleuromutilin Average Price (US$/Kg) of Key Manufacturers (2021–2026)

 Table 11. Global Key Players of Pleuromutilin, Industry Ranking, 2023 vs 2024 vs 2025

 Table 12. Global Key Manufacturers of Pleuromutilin, Manufacturing Sites and Headquarters

 Table 13. Global Key Manufacturers of Pleuromutilin, Product Types and Applications

 Table 14. Global Key Manufacturers of Pleuromutilin, Date of Entry into the Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Pleuromutilin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pleuromutilin Revenue, 2025

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Pleuromutilin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 19. Global Pleuromutilin Sales by Region (MT), 2021–2026

 Table 20. Global Pleuromutilin Sales Market Share by Region (2021–2026)

 Table 21. Global Pleuromutilin Sales by Region (MT), 2027–2032

 Table 22. Global Pleuromutilin Sales Market Share by Region (2027–2032)

 Table 23. Global Pleuromutilin Revenue by Region (US$ Million), 2021–2026

 Table 24. Global Pleuromutilin Revenue Market Share by Region (2021–2026)

 Table 25. Global Pleuromutilin Revenue by Region (US$ Million), 2027–2032

 Table 26. Global Pleuromutilin Revenue Market Share by Region (2027–2032)

 Table 27. North America Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 28. North America Pleuromutilin Sales by Country (MT), 2021–2026

 Table 29. North America Pleuromutilin Sales by Country (MT), 2027–2032

 Table 30. North America Pleuromutilin Revenue by Country (US$ Million), 2021–2026

 Table 31. North America Pleuromutilin Revenue by Country (US$ Million), 2027–2032

 Table 32. Europe Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 33. Europe Pleuromutilin Sales by Country (MT), 2021–2026

 Table 34. Europe Pleuromutilin Sales by Country (MT), 2027–2032

 Table 35. Europe Pleuromutilin Revenue by Country (US$ Million), 2021–2026

 Table 36. Europe Pleuromutilin Revenue by Country (US$ Million), 2027–2032

 Table 37. Asia Pacific Pleuromutilin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 38. Asia Pacific Pleuromutilin Sales by Region (MT), 2021–2026

 Table 39. Asia Pacific Pleuromutilin Sales by Region (MT), 2027–2032

 Table 40. Asia Pacific Pleuromutilin Revenue by Region (US$ Million), 2021–2026

 Table 41. Asia Pacific Pleuromutilin Revenue by Region (US$ Million), 2027–2032

 Table 42. Latin America Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 43. Latin America Pleuromutilin Sales by Country (MT), 2021–2026

 Table 44. Latin America Pleuromutilin Sales by Country (MT), 2027–2032

 Table 45. Latin America Pleuromutilin Revenue by Country (US$ Million), 2021–2026

 Table 46. Latin America Pleuromutilin Revenue by Country (US$ Million), 2027–2032

 Table 47. Middle East and Africa Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 48. Middle East and Africa Pleuromutilin Sales by Country (MT), 2021–2026

 Table 49. Middle East and Africa Pleuromutilin Sales by Country (MT), 2027–2032

 Table 50. Middle East and Africa Pleuromutilin Revenue by Country (US$ Million), 2021–2026

 Table 51. Middle East and Africa Pleuromutilin Revenue by Country (US$ Million), 2027–2032

 Table 52. Global Pleuromutilin Sales (MT) by Type (2021–2026)

 Table 53. Global Pleuromutilin Sales (MT) by Type (2027–2032)

 Table 54. Global Pleuromutilin Sales Market Share by Type (2021–2026)

 Table 55. Global Pleuromutilin Sales Market Share by Type (2027–2032)

 Table 56. Global Pleuromutilin Revenue (US$ Million) by Type (2021–2026)

 Table 57. Global Pleuromutilin Revenue (US$ Million) by Type (2027–2032)

 Table 58. Global Pleuromutilin Revenue Market Share by Type (2021–2026)

 Table 59. Global Pleuromutilin Revenue Market Share by Type (2027–2032)

 Table 60. Global Pleuromutilin Price (US$/Kg) by Type (2021–2026)

 Table 61. Global Pleuromutilin Price (US$/Kg) by Type (2027–2032)

 Table 62. Global Pleuromutilin Sales (MT) by Application (2021–2026)

 Table 63. Global Pleuromutilin Sales (MT) by Application (2027–2032)

 Table 64. Global Pleuromutilin Sales Market Share by Application (2021–2026)

 Table 65. Global Pleuromutilin Sales Market Share by Application (2027–2032)

 Table 66. Global Pleuromutilin Revenue (US$ Million) by Application (2021–2026)

 Table 67. Global Pleuromutilin Revenue (US$ Million) by Application (2027–2032)

 Table 68. Global Pleuromutilin Revenue Market Share by Application (2021–2026)

 Table 69. Global Pleuromutilin Revenue Market Share by Application (2027–2032)

 Table 70. Global Pleuromutilin Price (US$/Kg) by Application (2021–2026)

 Table 71. Global Pleuromutilin Price (US$/Kg) by Application (2027–2032)

 Table 72. Sunny Biotech Company Information

 Table 73. Sunny Biotech Description and Business Overview

 Table 74. Sunny Biotech Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 75. Sunny Biotech Pleuromutilin Product

 Table 76. Sunny Biotech Recent Developments/Updates

 Table 77. Hebei Weiyuan Company Information

 Table 78. Hebei Weiyuan Description and Business Overview

 Table 79. Hebei Weiyuan Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 80. Hebei Weiyuan Pleuromutilin Product

 Table 81. Hebei Weiyuan Recent Developments/Updates

 Table 82. Shandong Shengli Company Information

 Table 83. Shandong Shengli Description and Business Overview

 Table 84. Shandong Shengli Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 85. Shandong Shengli Pleuromutilin Product

 Table 86. Shandong Shengli Recent Developments/Updates

 Table 87. Shandong Lukang Company Information

 Table 88. Shandong Lukang Description and Business Overview

 Table 89. Shandong Lukang Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 90. Shandong Lukang Pleuromutilin Product

 Table 91. Shandong Lukang Recent Developments/Updates

 Table 92. Qingdao Dierman Company Information

 Table 93. Qingdao Dierman Description and Business Overview

 Table 94. Qingdao Dierman Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 95. Qingdao Dierman Pleuromutilin Product

 Table 96. Qingdao Dierman Recent Developments/Updates

 Table 97. Qilu Pharma Company Information

 Table 98. Qilu Pharma Description and Business Overview

 Table 99. Qilu Pharma Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 100. Qilu Pharma Pleuromutilin Product

 Table 101. Qilu Pharma Recent Developments/Updates

 Table 102. Huvepharma Company Information

 Table 103. Huvepharma Description and Business Overview

 Table 104. Huvepharma Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 105. Huvepharma Pleuromutilin Product

 Table 106. Huvepharma Recent Developments/Updates

 Table 107. Novartis Company Information

 Table 108. Novartis Description and Business Overview

 Table 109. Novartis Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 110. Novartis Pleuromutilin Product

 Table 111. Novartis Recent Developments/Updates

 Table 112. Vethellas Company Information

 Table 113. Vethellas Description and Business Overview

 Table 114. Vethellas Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 115. Vethellas Pleuromutilin Product

 Table 116. Vethellas Recent Developments/Updates

 Table 117. Elanco Company Information

 Table 118. Elanco Description and Business Overview

 Table 119. Elanco Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)

 Table 120. Elanco Pleuromutilin Product

 Table 121. Elanco Recent Developments/Updates

 Table 122. Key Raw Materials Lists

 Table 123. Raw Materials Key Suppliers Lists

 Table 124. Pleuromutilin Distributors List

 Table 125. Pleuromutilin Customers List

 Table 126. Pleuromutilin Market Trends

 Table 127. Pleuromutilin Market Drivers

 Table 128. Pleuromutilin Market Challenges

 Table 129. Pleuromutilin Market Restraints

 Table 130. Research Programs/Design for This Report

 Table 131. Key Data Information from Secondary Sources

 Table 132. Key Data Information from Primary Sources

 Table 133. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Pleuromutilin

 Figure 2. Global Pleuromutilin Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Pleuromutilin Market Share by Type: 2025 & 2032

 Figure 4. Premix Product Picture

 Figure 5. API Powder Product Picture

 Figure 6. Global Pleuromutilin Market Value by Salt Form (US$ Million), 2021–2032

 Figure 7. Global Pleuromutilin Market Share by Salt Form: 2025 vs 2032

 Figure 8. Fumarates Product Picture

 Figure 9. Tartrates Product Picture

 Figure 10. Others Product Picture

 Figure 11. Global Pleuromutilin Market Value by Indication Cluster (US$ Million), 2021–2032

 Figure 12. Global Pleuromutilin Market Share by Indication Cluster: 2025 vs 2032

 Figure 13. Respiratory Product Picture

 Figure 14. Digestiv Product Picture

 Figure 15. Other Product Picture

 Figure 16. Global Pleuromutilin Market Value by Application (US$ Million), 2021–2032

 Figure 17. Global Pleuromutilin Market Share by Application: 2025 & 2032

 Figure 18. Livestock

 Figure 19. Poultry

 Figure 20. Global Pleuromutilin Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 21. Global Pleuromutilin Market Size (US$ Million), 2021–2032

 Figure 22. Global Pleuromutilin Sales (MT), 2021–2032

 Figure 23. Global Pleuromutilin Average Price (US$/Kg), 2021–2032

 Figure 24. Pleuromutilin Report Years Considered

 Figure 25. Pleuromutilin Sales Share by Manufacturers in 2025

 Figure 26. Global Pleuromutilin Revenue Share by Manufacturers in 2025

 Figure 27. Top 5 and Top 10 Global Pleuromutilin Players: Market Share by Revenue in Pleuromutilin in 2025

 Figure 28. Pleuromutilin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 29. Global Pleuromutilin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 30. North America Pleuromutilin Sales Market Share by Country (2021–2032)

 Figure 31. North America Pleuromutilin Revenue Market Share by Country (2021–2032)

 Figure 32. United States Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 33. United States Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 34. Canada Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 35. Europe Pleuromutilin Sales Market Share by Country (2021–2032)

 Figure 36. Europe Pleuromutilin Revenue Market Share by Country (2021–2032)

 Figure 37. Germany Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. Poland Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 39. UK Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Italy Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Russia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 42. Rest of Europe Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 43. Asia Pacific Pleuromutilin Sales Market Share by Region (2021–2032)

 Figure 44. Asia Pacific Pleuromutilin Revenue Market Share by Region (2021–2032)

 Figure 45. China Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. Japan Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. South Korea Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. India Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 49. Australia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 50. China Taiwan Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 51. Southeast Asia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 52. Latin America Pleuromutilin Sales Market Share by Country (2021–2032)

 Figure 53. Latin America Pleuromutilin Revenue Market Share by Country (2021–2032)

 Figure 54. Mexico Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 55. Brazil Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Argentina Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 57. Middle East and Africa Pleuromutilin Sales Market Share by Country (2021–2032)

 Figure 58. Middle East and Africa Pleuromutilin Revenue Market Share by Country (2021–2032)

 Figure 59. Turkey Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 60. Saudi Arabia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 61. UAE Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032

 Figure 62. Global Sales Market Share of Pleuromutilin by Type (2021–2032)

 Figure 63. Global Revenue Market Share of Pleuromutilin by Type (2021–2032)

 Figure 64. Global Pleuromutilin Price (US$/Kg) by Type (2021–2032)

 Figure 65. Global Sales Market Share of Pleuromutilin by Application (2021–2032)

 Figure 66. Global Revenue Market Share of Pleuromutilin by Application (2021–2032)

 Figure 67. Global Pleuromutilin Price (US$/Kg) by Application (2021–2032)

 Figure 68. Pleuromutilin Value Chain

 Figure 69. Channels of Distribution (Direct Vs Distribution)

 Figure 70. Bottom-up and Top-down Approaches for This Report

 Figure 71. Data Triangulation

 Figure 72. Key Executives Interviewed